KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Aurinia Pharmaceuticals (AUPH) Profit After Tax: 2014-2024

Historic Profit After Tax for Aurinia Pharmaceuticals (AUPH) over the last 10 years, with Dec 2024 value amounting to $5.8 million.

  • Aurinia Pharmaceuticals' Profit After Tax rose 119.87% to $31.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $77.8 million, marking a year-over-year increase of 445.14%. This contributed to the annual value of $5.8 million for FY2024, which is 107.37% up from last year.
  • As of FY2024, Aurinia Pharmaceuticals' Profit After Tax stood at $5.8 million, which was up 107.37% from -$78.0 million recorded in FY2023.
  • Aurinia Pharmaceuticals' 5-year Profit After Tax high stood at $5.8 million for FY2024, and its period low was -$181.0 million during FY2021.
  • Moreover, its 3-year median value for Profit After Tax was -$78.0 million (2023), whereas its average is -$60.1 million.
  • Per our database at Business Quant, Aurinia Pharmaceuticals' Profit After Tax plummeted by 76.24% in 2021 and then soared by 107.37% in 2024.
  • Aurinia Pharmaceuticals' Profit After Tax (Yearly) stood at -$102.7 million in 2020, then slumped by 76.24% to -$181.0 million in 2021, then spiked by 40.22% to -$108.2 million in 2022, then increased by 27.88% to -$78.0 million in 2023, then skyrocketed by 107.37% to $5.8 million in 2024.